Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Pende

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
HLA|June 10, 2019
Report from the Eleventh Killer Immunoglobulin-like Receptor (KIR) Workshop: Novel insights on KIR polymorphism, ligand recognition, expression and functionMichela Falco, Simona Sivori, Raffaella Meazza, et al.
Molecular Immunology|June 29, 2004
Learning how to discriminate between friends and enemies, a lesson from Natural Killer cellsCristina Bottino, Lorenzo Moretta, Daniela Pende, et al.
Clinical Immunology (Orlando, Fla.)|November 5, 2018
2B4 dysfunction in XLP1 NK cells: More than inability to control EBV infectionDaniela Pende, Raffaella Meazza, Stefania Marcenaro, et al.
Blood|April 16, 2010
Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infectionAura Muntasell, Giuliana Magri, Daniela Pende, et al.
Developmental and Comparative Immunology|January 8, 2008
Natural killer cells in lymph nodes of healthy calves express CD16 and show both cytotoxic and cytokine-producing propertiesPreben Boysen, Gjermund Gunnes, Daniela Pende, et al.
European Journal of Immunology|May 1, 2002
Human natural killer cells: their origin, receptors and functionLorenzo Moretta, Cristina Bottino, Daniela Pende, et al.
Innate Immunity|October 18, 2013
Identification of CD300a as a new hypoxia-inducible gene and a regulator of CCL20 and VEGF production by human monocytes and macrophagesFederica Raggi, Fabiola Blengio, Alessandra Eva, et al.
Immunology Letters|August 20, 2005
Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysisLorenzo Moretta, Cristina Bottino, Daniela Pende, et al.
Immunology Letters|July 26, 2003
Cellular and molecular basis of natural killer and natural killer-like activityLorenzo Moretta, Maria Cristina Mingari, Cristina Bottino, et al.
HLA|March 5, 2019
Natural killer cells: From surface receptors to the cure of high-risk leukemia (Ceppellini Lecture)Michela Falco, Daniela Pende, Enrico Munari, et al.
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
HLA|June 10, 2019
Report from the Eleventh Killer Immunoglobulin-like Receptor (KIR) Workshop: Novel insights on KIR polymorphism, ligand recognition, expression and functionMichela Falco, Simona Sivori, Raffaella Meazza, et al.
Molecular Immunology|June 29, 2004
Learning how to discriminate between friends and enemies, a lesson from Natural Killer cellsCristina Bottino, Lorenzo Moretta, Daniela Pende, et al.
Clinical Immunology (Orlando, Fla.)|November 5, 2018
2B4 dysfunction in XLP1 NK cells: More than inability to control EBV infectionDaniela Pende, Raffaella Meazza, Stefania Marcenaro, et al.
Blood|April 16, 2010
Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infectionAura Muntasell, Giuliana Magri, Daniela Pende, et al.
Developmental and Comparative Immunology|January 8, 2008
Natural killer cells in lymph nodes of healthy calves express CD16 and show both cytotoxic and cytokine-producing propertiesPreben Boysen, Gjermund Gunnes, Daniela Pende, et al.
European Journal of Immunology|May 1, 2002
Human natural killer cells: their origin, receptors and functionLorenzo Moretta, Cristina Bottino, Daniela Pende, et al.
Innate Immunity|October 18, 2013
Identification of CD300a as a new hypoxia-inducible gene and a regulator of CCL20 and VEGF production by human monocytes and macrophagesFederica Raggi, Fabiola Blengio, Alessandra Eva, et al.
Immunology Letters|August 20, 2005
Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysisLorenzo Moretta, Cristina Bottino, Daniela Pende, et al.
Immunology Letters|July 26, 2003
Cellular and molecular basis of natural killer and natural killer-like activityLorenzo Moretta, Maria Cristina Mingari, Cristina Bottino, et al.
HLA|March 5, 2019
Natural killer cells: From surface receptors to the cure of high-risk leukemia (Ceppellini Lecture)Michela Falco, Daniela Pende, Enrico Munari, et al.
Pageof 11